Aristotle Atlantic Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,032
| Closed | -$283K | – | 91 |
|
|
2024
Q3 | $283K | Sell |
4,032
-29,278
| -88% | -$2.06M | 0.01% | 88 |
|
|
2024
Q2 | $2.74M | Sell |
33,310
-760
| -2% | -$62.6K | 0.09% | 75 |
|
|
2024
Q1 | $2.98M | Sell |
34,070
-1,260
| -4% | -$110K | 0.1% | 74 |
|
|
2023
Q4 | $3.41M | Buy |
35,330
+521
| +1% | +$50.2K | 0.12% | 74 |
|
|
2023
Q3 | $3.08M | Buy |
34,809
+11,837
| +52% | +$1.05M | 0.12% | 75 |
|
|
2023
Q2 | $1.99M | Buy |
22,972
+17,491
| +319% | +$1.52M | 0.08% | 81 |
|
|
2023
Q1 | $533K | Buy |
+5,481
| New | +$533K | 0.03% | 90 |
|
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$2.09M | – | 100 |
|
|
2021
Q2 | $2.09M | Hold |
25,000
| – | – | 0.14% | 77 |
|
|
2021
Q1 | $1.89M | Hold |
25,000
| – | – | 0.14% | 77 |
|
|
2020
Q4 | $2.19M | Hold |
25,000
| – | – | 0.17% | 72 |
|
|
2020
Q3 | $1.9M | Hold |
25,000
| – | – | 0.17% | 68 |
|
|
2020
Q2 | $3.08M | Hold |
25,000
| – | – | 0.3% | 47 |
|
|
2020
Q1 | $2.11M | Hold |
25,000
| – | – | 0.32% | 43 |
|
|
2019
Q4 | $2.11M | Hold |
25,000
| – | – | 0.27% | 48 |
|
|
2019
Q3 | $1.69M | Hold |
25,000
| – | – | 0.49% | 40 |
|
|
2019
Q2 | $2.14M | Hold |
25,000
| – | – | 0.62% | 30 |
|
|
2019
Q1 | $2.22M | Hold |
25,000
| – | – | 0.67% | 29 |
|
|
2018
Q4 | $2.13M | Sell |
25,000
-200
| -0.8% | -$17K | 0.75% | 29 |
|
|
2018
Q3 | $2.42M | Hold |
25,200
| – | – | 1.48% | 22 |
|
|
2018
Q2 | $2.37M | Sell |
25,200
-7,200
| -22% | -$678K | 0.82% | 29 |
|
|
2018
Q1 | $2.63M | Hold |
32,400
| – | – | 0.95% | 24 |
|
|
2017
Q4 | $2.89M | Buy |
+32,400
| New | +$2.89M | 1.04% | 20 |
|